Clinical Characteristics and Outcomes Among STEMI Patients With Cardiogenic Shock at Abu Dhabi City

Recruiting now

Conditions studied: ST Elevation Myocardial Infarction, Cardiogenic Shock

In brief

A retrospective study on the clinical characteristics and treatment outcomes of patients admitted with ST-elevation Myocardial Infarction (STEMI) complicated with cardiogenic shock (CS) during admission or CS development during their hospital stay for two tertiary hospitals in Abu Dhabi, UAE, from 2020-2024.

Key facts

Study ID

NCT06535503

Run by

Abu Dhabi Health Services Company

People needed

400

Starts

2024-07-01

Expected to finish

2025-05-30

Last updated by the study team

2025-02-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age more than 18.
• STEMI complicated by cardiogenic shock.
• Were hospitalized or treated at SSMC or SKMC for STEMI complicated by cardiogenic shock.
• Patient admitted between January 2019 to March 2024.

You may not qualify if…

• Age less than 18.
• Shock patient not related to Myocardial infarction.
• NSTEMI-related cardiogenic shock.
• Patients who were not treated at SSMC or SKMC for the STEMI complicated by cardiogenic shock.
• Patient not admitted between January 2019 to March 2024.

Where it is running

• Sheikh Khalifa Medical City (SKMC) — Abu Dhabi, Abu Dhabi Emirate, United Arab Emirates (enrolling)
• Sheikh Shakhbout Medical City (SKMC) — Abu Dhabi, Abu Dhabi Emirate, United Arab Emirates (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.